The emergence of Covid 19 at the start of 2020 set the alarm for a new pandemic around the world following the turning century. Global efforts to fight against infectious diseases focus on protecting citizens from the virus, preventing the spread of the virus within and through a country, and promoting the idea of the dangers of the virus and ways of self-preservation. On a neurophysiological scale, ideal and effective strategies such as initiating quarantine around the world, in which a limit to the outside world is set, gradually stagnate the spread of the virus and maintain the optimum environment for the sick to recover. The mandatory policy and consensus around the world of wearing a mask and maintaining a six-foot distance substantially curbed the spread of the virus in public. On a microbiological scale, the technological advancement the world experienced in recent years resulted in the rapid development of public preventative treatment, such as vaccines, marking the turning point regarding the gradual decrease in the spread and, subsequently, the rate of death throughout the world. The methods of preventing the spread of disease, as well as protecting the citizens from further damage, have led to an exponential decay of cases regarding the coronavirus.

In recent years, the prevalence of depression and suicide rates have continued to increase, especially among adolescents, and existing treatment methods are still incomplete and have certain limitations. Although some progress has been made in studying the relationship between gut microbiota and depression, a clear explanation of the physiological mechanisms of the "Microbiota-Gut-Brain Axis" (MGBA) and a review of treatments for depression based on MGBA regulation are still lacking. This article examines the traits of the gut microbiota in patients with depression, highlighting that their richness and diversity are significantly lower compared to healthy controls. The neurological, endocrine and immune mechanisms of MGBA and its role in the pathogenesis of depression were further explored. This article also reviews MGBA-based treatments, such as Fecal Microbiota Transplantation (FMT) and probiotic therapy, noting their potential efficacy in alleviating depressive symptoms. This article unveils the pivotal role of gut microbiota in the development of depression, offering a new avenue for researching the pathological mechanisms of the disorder and laying a scientific foundation for creating novel antidepressant treatments. At present, there is no consistent conclusion about the changes in the composition of the intestinal flora in depression. Future studies can expand the sample size and conduct experiments on different groups to deeply reveal the changes in the intestinal flora of patients with depression.

Parkinson's disease (PD) is a neurodegenerative disease that primarily affects middle-aged and older adults. Its incidence is second only to that of Alzheimer's disease. The primary source of clinical symptoms is the degradation and death of dopaminergic neurons in the substantia nigra-striatum. Patients mainly show motor symptoms such as static tremor, rigidity, bradykinesia and postural instability, and non-motor symptoms such as sensory disturbance, autonomic nervous dysfunction and mental cognitive impairment. There is no proven way to cure the disease or to slow its progression through neuroprotection, therefore treatment focuses mostly on treating symptoms. This study examines the shared pathophysiology of PD, which includes inflammation, abnormalities in protein handling, oxidative stress, and mitochondrial dysfunction. Next it discusses the available PD treatment options, which include standard medication therapy, promising surgical procedures, gene therapy, and new approaches to individualized PD care. The safety and usefulness of many treatments are still unknown, though. Hope that as life science and technology advance, the etiology of Parkinson's disease will become clearer and more dependable treatment options will be created to enhance sufferers' quality of life.

Cancer of the cervical region, which is caused by highly susceptible HPV types and serves as the fourth leading malignancy to develop in women worldwide, is the main public health objective of the HPV vaccine. Furthermore, it is imperative that you prevent genital warts and malignancies, including anal, oral, and vaginal cancers, that are associated with high risk HPV. Currently, nevertheless, there exist regional and national differences in the prevalence of HPV infection and vaccination as well as within various populations. In order to provide relevant recommendations for future research on the relevant situation, this paper analyzes the literature on the mechanism of action and application of the nine-valent and quadrivalent HPV vaccines, in addition to the technological innovation and development of vaccine R&D, challenges associated with vaccine R&D, and future development trends. Though future research can concentrate on the study of other cancers produced by HPV in other pertinent directions, this publication concentrates on the study of cervical cancers caused by high-risk HPV strains. Future research can look on linked cancers.

As cardiovascular and cerebrovascular diseases (CVDs) in children are receiving increasing attention, the background is that CVDs at different age stages present different characteristics. Currently, some progress has been made in age-specific targeted therapeutic studies, but the refinement and optimisation of the overall treatment strategy still needs to be deepened. The research gap lies in the lack of a comprehensive and systematic comparison of treatment strategies for different age groups. This paper have analysed the differences and commonalities of CVD treatment strategies in different age groups, and obtained the relevant results of optimised strategies in each age group. Treatment for children must take into account the effects on growth and development, adolescents need to focus on prevention and correction, and the elderly require comprehensive management. This is of great significance in improving the treatment effect of CVD in children and provides a comprehensive reference for future studies, but the long-term effect assessment and individual difference response are still not fully resolved, and future studies can focus on further exploration in these directions.

HIV causes a serious infectious disease called AIDS, which has a serious impact on human health and social stability, and many celebrities have even been diagnosed with the disease. There is no cure for HIV-induced AIDS, but antiretroviral therapy can, to a certain extent, strengthen the immune system and help the body fight off other diseases. However, more exploration is still needed. This paper analyses several relatively novel treatment options, preventive measures and public health strategies, and proposes some possible breakthroughs to solve the HIV problem as well as directions for future efforts. Firstly, it briefly describes the pathways and effects of HIV infection, and clarifies the mode of transmission and the importance of HIV. It then describes traditional treatment modalities and innovative treatment options, and presents future perspectives. It concludes with an overview of preventive measures and public health strategies for HIV. Standing on the shoulders of those who have gone before, a cure for HIV seems to be getting closer. It is hoped that the review in this article will give readers a deeper understanding of HIV-related treatment and prevention in the last three years or even the last year, and contribute to the ultimate cure of HIV.

Alzheimer's disease (hereafter referred to as AD), which is a neurodegenerative malady, featured basically by memory deficiency and cognitive decrease, has been increasingly linked to immune system dynamics in recent studies. This paper aims to review experimental studies that elucidate the relationship between AD and alterations in immune cell functionality. Recent research has shown progress in this area through experiments, highlighting quantitative and functional shifts in T cells, macrophages, neutrophils, and B cells on the growth of AD. The assay insinuates pro-inflammatory cells rising and a decrease in inflammation-suppressing cells. These findings offer valuable insights for future mechanistic investigations and drug development. However, there remain numerous unexplored aspects in this field, such as specific factors exacerbating AD, drug treatments, and the identification of signaling pathways. Future research may benefit from focusing on uncovering signaling pathways as a key avenue for further exploration and understanding.

This article focuses on COVID-19 during different times, from 2019 to 2024. Which include the background of COVID-19, structures, prevention spread ways and vaccines. Introducing these things about COVID-19 can help people know more about this various, although COVID-19 does not affect humans as much as it used to, and can help people know what got improved during the COVID-19 time, such as the vaccine. By reading this article, people can know more about the details of COVID-19 and can also know more ways to protect themselves. Also, readers can know different kinds of the variant with time goes then appears in the world, and development in the vaccine. This paper explores COVID-19's impact on humanity, the evolution of the virus, and advances in vaccines and treatments, providing insights into the pandemic's progression and response.

With 38 million HIV-positive individuals living worldwide, HIV/AIDS is a fatal and rigorous threat to build up a global health society. It is critical to optimize the allocation of public health resources for improving the life quality of HIV/AIDS patients in the U.S. Meanwhile, the inevitable mission of confirming HIV diagnosis receive comprehensive care, reduce HIV disparities among marginalized populations, and implement effective prevention measures. This article analyzes the allocation of public health resources for HIV/AIDS in the United States, including key issues such as funding allocation, medical infrastructure, targeted interventions, and health equity. A thorough assessment of the affordability of HIV-related medical services and their interventions' efficacy is executed. At the same time, this article also focuses on the effectiveness of PrEP. Although PrEP has been proven to be effective, its promotion still faces problems such as insufficient awareness, financial barriers, limited access, and social stigma. To address these challenges, it is necessary to strengthen public education, train medical providers, reduce PrEP costs, expand access, and combat stigma through public awareness campaigns and legal protection. This comprehensive approach is consistent with a broader public health strategy aimed at slowing HIV transmission and achieving sustained viral suppression.

Tularemia is a zoonosis caused by gram-negative bacteria Francisella tularensis, which has LPS in outer membrane. Lipid A is the most conservative part in LPS and is important for LPS function of bacteria survival and host immune response stimulation. For a certain strain, the lipid A structure is unique, but can also influenced by different environmental conditions. The mechanisms of how lipid A synthesis and modification changes will affect immune mechanism still remain many questions. This article briefly introduces the enzymes participating general lipid A synthesis process. F. novicida, as a specific example, has differences in lipid A-related enzymes from those of ordinary bacteria. Lipid A structure and content can be regulated by some environment conditions like temperature differences between environment and host cells. The structure of lipid A determines its function, so bacterial virulence is various. Some F. novicida knockout mutants have no ability to stimulate immune response in host cells and have lower toxicity than wild-type strains. In therapy, modified lipid A is used as immune adjuvant and some lipid A mutant strains can be vaccines to protect animals against lethal Francisella strain infection. A deeper understanding of Francisella lipid A structure, regulation and immune mechanisms helps to prevent and treat tularemia disease. In future research, more enzymes affecting characteristics of lipid A or the whole LPS can be further studied. More effective vaccines and drug design relies on a better understanding of pathogenic mechanisms.